key: cord-1021434-nsz8hmil
authors: Rodrigo, Mourão; Diogo, Correa; Nina, Ventura; Ronaldo, Pereira
title: Tomographic findings and thrombogenic effects of COVID-19
date: 2020-07-13
journal: J Am Coll Radiol
DOI: 10.1016/j.jacr.2020.06.034
sha: c4838488537e89bc4dedfa997373e61befa5b998
doc_id: 1021434
cord_uid: nsz8hmil

nan

Dear Editor, Since December 2019, the infection by the Severe acute respiratory syndrome coronavirus 2 (Sars-Cov-2) has progressively affected the population of several countries around the world 1 . In this context, computed tomography (CT) has become an important auxiliary tool in the management of this disease, used to confirm pulmonary involvement, identify complications, and define the prognosis 1 . Among the different publications about the topic, the study entitled "Coronavirus disease 2019 (COVID-19) CT findings: a systematic review and meta-analysis" called our attention. We would like to discuss the contribution of thrombogenic effects of the virus to tomographic findings and ask the authors if pulmonary thromboembolism was considered in the study.

Ground glass and consolidation areas are commonly found in chest tomography, not being specific for any particular pathology, occurring in different viral pneumonia due to diffuse alveolar edema and interstitial inflammation 1 . In consequence, pulmonary infection by COVID-19 or by other coronaviruses diseases, including Severe acute respiratory syndrome and the Middle East respiratory syndrome, can be similar in CT 1 .

However, in the current scenario, these findings in peripheral and bilateral distribution are the main form of identification of lung involvement by the coronavirus, especially when located in the lower lobes 1 .

Another critical point, also identified in these months, was the predisposition to venous and arterial thrombotic complications 2 , described in patients admitted to intensive care units and in general wards, even using prophylactic anticoagulants 3 .

Hereupon, several studies have observed a correlation between coagulopathy and Sars-Cov-2 infection 3 , with cases of deep vein thrombosis, thrombosis of the extracorporeal circulation circuits, pulmonary thromboembolism, and even arterial thrombosis having been reported 3 . We have some cases of thromboembolism related to confirmed coronavirus infection. Within this framework, different factors may be related to this condition, such as direct cellular injury by the virus, excessive inflammatory response, hypoxia, immobilization, and diffuse intravascular coagulation 2 .

When a pathogen enters our organism, the inflammatory response is activated, stimulating defense cells and the coagulation cascade to prevent microorganisms spread throughout the organs and tissues 4 . Infection by Sars-Cov-2 stimulates a procoagulant activity related to inflammatory mechanisms through increased levels of fibrinogen, thrombin regeneration, plasminogen activator inhibitor-1, a direct endothelial injury that exposes the tissue factor, which leads to the activation of the coagulation cascade, as well as, a reduced level of urokinase-type plasminogen activator 4 . In this perspective, the chest tomography is remarkable, because arterial and venous vaso-occlusive diseases in the lungs can be seen as ground-glass opacity or consolidation, representing pulmonary infarction with or without hemorrhage into the airspaces in histopathology 5 .

In conclusion, it is possible to consider that the findings on chest CT may represent not only the direct lung involvement in the airways by the virus itself, as previously described. It is also probable that thrombogenic and embolic events in large vessels, identified on angiotomography, and in the microvasculature, which tomography cannot directly identify, may be related.

Coronavirus disease 2019 (COVID-19) CT findings: a systematic review and meta-analysis

Incidence of thrombotic complications in critically ill ICU patients with COVID-19: Thrombosis research

Incidence of venous thromboembolism in hospitalized patients with COVID 19

Coagulopathy of Coronavirus Disease

Small-vessel diseases of the lung: CT-pathologic correlates